PULSE 11/20/2026: NYRx MSSNY Meeting Recap
NYRx MSSNY Meeting Recap Click to Enlarge Practitioner Administered Drug went live for Fee-for-Service members on November 19. The Preferred Drug List has been renamed NYRx Clinical Criteria and Cover Guide and is in ADA-compliant formatting. Vyvanse and Carbatrol have been
PULSE 11/20/2026: Dispute Processing is Available in the IDR Gateway
Dispute Processing is Available in the IDR Gateway Click to Enlarge Beginning November 13, 2026, organizations with IDR Gateway accounts can submit “Notice of IDR Initiation,” “Notice of IDR Initiation Response,” “Notice of Certified IDR Entity Selection,” and “Notice of
PULSE 11/13/2026: Action Alert: Incorrect Insurer Processing of Office-Administered Drugs (UnitedHealthcare)
Action Alert: Incorrect Insurer Processing of Office-Administered Drugs (UnitedHealthcare) Click to Enlarge MSSNY is currently tracking a systematic claims processing issue involving UnitedHealthcare and physician-administered drugs billed on CMS-1500 claims forms. What Happened The Issue: Claims for physician-administered drugs given
PULSE 10/23/2026: Provider-Administered Drugs Webinar Update
Provider-Administered Drugs Webinar Update Click to Enlarge NYRx, the Medicaid Drug Program, will host an additional webinar on PADs (Provider-Administered Drugs) on Monday, November 9 at 10:00 AM. Physicians are welcome to attend. The presentation will share updates and provide
PULSE 10/16/2026: NYRx: PDL & Prior Auth Updates
NYRx Cost Optimization Program Update Click to Enlarge NYRx’s September 10 Cost Optimization update and current Preferred Drug List (PDL) are available. Additional PDL and Brand Less Than Generic (BLTG) changes are scheduled for October 22. Beginning in November, prior
PULSE 7/31/2026: Payment & Practice: Turning Complex Payer Challenges Into $45 Million Recovered Revenue
Payment & Practice: Turning Complex Payer Challenges Into $45 Million Recovered Revenue Click to Enlarge Payer disputes can drain time, revenue, and staff capacity from practices already managing rising costs, workforce pressures, and growing administrative demands. For New York physicians,
PULSE 7/24/2026: NYRx Cost Optimization Program Update
NYRx Cost Optimization Program Update Click to Enlarge The New York State Medicaid Pharmacy Program (NYRx) has expanded its Cost Optimization Program, effective July 16, 2026, by adding additional high-cost drug formulations and dosages that are significantly more expensive than
PULSE Pulse 6/26/2026: NYRx Updates: Resources Available for Review
NYRx Updates: Resources Available for Review Click to Enlarge MSSNY recognizes that keeping pace with Medicaid pharmacy policy changes can be challenging amid growing administrative responsibilities. We encourage physicians, practice managers, billing teams, and clinical staff to review the available
PULSE 5/8/2026: Attention Physicians: Are You Being Underpaid by Optum?
Attention Physicians: Are You Being Underpaid by Optum? Click to Enlarge If you are billing CPT code 95165 and are being underpaid by Optum, please email our Physician Payment and Practice Division, as we may be able to help.
PULSE 4/17/2026: Payment & Practice: Turning Complex Payer Challenges Into $38 Million Recovered Revenue
Payment & Practice: Turning Complex Payer Challenges Into $38 Million Recovered Revenue Click to Enlarge Key Point: MSSNY’s Payment and Practice team has recovered $38 million since 2021, including $10.8 million so far in 2026, directly returning revenue to physician practices.Why It

